Apellis Pharmaceuticals shares owned by J. Goldman & Co
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by J. Goldman & Co
from 13F filings
Historical chart of J. Goldman & Co investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by J. Goldman & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 640k | 22.63 |
| 2025-06-30 | $4.4M | 257k | 17.31 |
| 2023-09-30 | $2.6M | 68k | 38.04 |
| 2023-06-30 | $2.0M | 22k | 91.10 |
| 2023-03-31 | $6.0M | 91k | 65.96 |
| 2022-09-30 | $3.7M | 54k | 68.30 |
| 2022-03-31 | $2.1M | 40k | 50.82 |
| 2021-12-31 | $2.3M | 48k | 47.28 |
| 2021-03-31 | $579k | 14k | 42.89 |